CCT-251921
CAS No. 1607837-31-9
CCT-251921 ( CCT 251921;CCT251921 )
Catalog No. M12311 CAS No. 1607837-31-9
A potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 210 | Get Quote |
|
10MG | 308 | Get Quote |
|
25MG | 519 | Get Quote |
|
50MG | 744 | Get Quote |
|
100MG | 1017 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCT-251921
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively.
-
DescriptionA potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively; reduces STAT1 Ser727 phosphorylation, inhibits tunor growth of APC-mutant SW620 human colorectal carcinoma xenograft mode, has pharmacokinetic, and physicochemical properties.
-
SynonymsCCT 251921;CCT251921
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1607837-31-9
-
Formula Weight410.91
-
Molecular FormulaC21H23ClN6O
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 28 mg/mL. 68.14 mM
-
SMILESO=C1NCCC12CCN(C3=C(Cl)C(N)=NC=C3C4=CC5=C(N(C)N=C5)C=C4)CC2
-
Chemical Name8-(2-Amino-3-chloro-5-(1-methyl-1H-indazol-5-yl)pyridin-4-yl)-2,8-diazaspiro[4.5]decan-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mallinger A, et al. J Med Chem. 2016 Feb 11;59(3):1078-101.
molnova catalog
related products
-
BUR1
BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.
-
PF07104091
PF-07104091 inhibits CDK2, which may lead to cell cycle arrest, induce apoptosis and inhibit tumor cell proliferation.
-
Flavopiridol
A potent, ATP-competetive CDKs inhibitor with IC50 of 30, 170, 100 nM for CDk1, 2, 4, respectively.